NDC 0069-0324

NYVEPRIA

Pegfilgrastim-apgf

NYVEPRIA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Pegfilgrastim.

Product ID0069-0324_1995cf41-7843-4402-a82b-c093f249c016
NDC0069-0324
Product TypeHuman Prescription Drug
Proprietary NameNYVEPRIA
Generic NamePegfilgrastim-apgf
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-12-15
Marketing CategoryBLA / BLA
Application NumberBLA761111
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NamePEGFILGRASTIM
Active Ingredient Strength6 mg/.6mL
Pharm ClassesGranulocyte Colony-Stimulating Factor [CS],Granulocyte-Macrophage Colony-Stimulating Factor [CS],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0069-0324-01

1 CARTON in 1 CARTON (0069-0324-01) > 1 SYRINGE in 1 CARTON > .6 mL in 1 SYRINGE
Marketing Start Date2020-12-15
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [NYVEPRIA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NYVEPRIA
NYVEPRIA
88693853 not registered Live/Pending
Hospira, Inc.
2019-11-15
NYVEPRIA
NYVEPRIA
87261611 not registered Live/Pending
Hospira, Inc.
2016-12-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.